Literature DB >> 12136536

Risk assessment in patients with ruptured abdominal aortic aneurysms.

H W Kniemeyer1, P U Reber, T Kessler, H Beckmann, H Hakki.   

Abstract

OBJECTIVES: Surgery of ruptured abdominal aortic aneurysms is associated with a high mortality rate, mostly related to multi-organ-failure after a prolonged intensive care therapy. In a retrospective study attempts are made to identify individual organ-dysfunction risk profiles influencing the outcome.
METHODS: Fifty seven patients (53 men, 4 women, mean age 71.8 +/- 8.8 years) with ruptured abdominal aortic aneurysms underwent graft replacement in a three year period. Fourty eight preoperative, 13 intraoperative and 34 postoperative variables were analyzed. A multi-organ dysfunction (MOD) score was used.
RESULTS: The perioperative mortality rate was 31%. Significance of pre-existing risk factors at admission was identified only for cardiovascular diseases. Multiple linear regression analysis indicated that hemoglobin < 90 g/l, systolic blood pressure < 80 mmHg and ECG signs of ischemia at admission are highly significant risk factors. Patients, who died later than 48 hours postoperatively, deceased mainly from MOD (93%) and required intensive care significantly longer than surviving patients (p < 0.0005). All patients with a MOD score > or = 4 died (n = 7). These patients required 26% of all ICU-days and 72% of the ICU-days of the nonsurvivors.
CONCLUSION: Patients with ruptured aortic aneurysms should not be excluded from treatment. However, a physiological scoring system after 48 h appears justifiable in order to decide on the appropriateness of continued ICU support.

Entities:  

Mesh:

Year:  2002        PMID: 12136536     DOI: 10.1080/00015458.2002.11679289

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  1 in total

1.  Prognostic factors associated with mortality in patients undergoing emergency surgery for abdominal aortic aneurysms.

Authors:  Yukari Koga; Yasunori Mishima; Masato Hara; Teruyuki Hiraki; Kazuo Ushijima
Journal:  J Anesth       Date:  2011-06-24       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.